577 related articles for article (PubMed ID: 15355986)
1. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
2. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
3. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
4. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Shenoy SK; Karnik SS; Hunyady L; Luttrell LM; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10782-7. PubMed ID: 12949261
[TBL] [Abstract][Full Text] [Related]
5. The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network.
Kendall RT; Strungs EG; Rachidi SM; Lee MH; El-Shewy HM; Luttrell DK; Janech MG; Luttrell LM
J Biol Chem; 2011 Jun; 286(22):19880-91. PubMed ID: 21502318
[TBL] [Abstract][Full Text] [Related]
6. beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation.
Barnes WG; Reiter E; Violin JD; Ren XR; Milligan G; Lefkowitz RJ
J Biol Chem; 2005 Mar; 280(9):8041-50. PubMed ID: 15611106
[TBL] [Abstract][Full Text] [Related]
7. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.
Ahn S; Shenoy SK; Wei H; Lefkowitz RJ
J Biol Chem; 2004 Aug; 279(34):35518-25. PubMed ID: 15205453
[TBL] [Abstract][Full Text] [Related]
8. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
[TBL] [Abstract][Full Text] [Related]
9. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
10. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
[TBL] [Abstract][Full Text] [Related]
11. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.
Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG
J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203
[TBL] [Abstract][Full Text] [Related]
13. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
Qian H; Pipolo L; Thomas WG
Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
[TBL] [Abstract][Full Text] [Related]
14. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.
Ahn S; Wei H; Garrison TR; Lefkowitz RJ
J Biol Chem; 2004 Feb; 279(9):7807-11. PubMed ID: 14711824
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
[TBL] [Abstract][Full Text] [Related]
17. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
[TBL] [Abstract][Full Text] [Related]
19. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis.
Hunton DL; Barnes WG; Kim J; Ren XR; Violin JD; Reiter E; Milligan G; Patel DD; Lefkowitz RJ
Mol Pharmacol; 2005 Apr; 67(4):1229-36. PubMed ID: 15635042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
